Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
D000818:Animals; D001921:Brain / Q000201:enzymology*; D006146:Guanidines / Q000494:pharmacology*; D006834:Hydrazines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology; D008297:Male; D008995:Monoamine Oxidase; D010293:Pargyline / Q000494:pharmacology*; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology*
D006146:Guanidines; D006834:Hydrazines; D014191:Tranylcypromine; D010293:Pargyline; D007490:Iproniazid; D008995:Monoamine Oxidase